Inoue, T.; Kanaji, N.; Nakamura, T.; Yokohira, M.; Komori, Y.; Ohara, Y.; Mizoguchi, H.; Watanabe, N.; Kadowaki, N.
Antitumor Effects of Combination Therapy with Oncolytic Vaccinia Virus and Tepotinib on Lung Cancer Cells. Cancers 2025, 17, 2681.
https://doi.org/10.3390/cancers17162681
AMA Style
Inoue T, Kanaji N, Nakamura T, Yokohira M, Komori Y, Ohara Y, Mizoguchi H, Watanabe N, Kadowaki N.
Antitumor Effects of Combination Therapy with Oncolytic Vaccinia Virus and Tepotinib on Lung Cancer Cells. Cancers. 2025; 17(16):2681.
https://doi.org/10.3390/cancers17162681
Chicago/Turabian Style
Inoue, Takuya, Nobuhiro Kanaji, Takafumi Nakamura, Masanao Yokohira, Yuta Komori, Yasuhiro Ohara, Hitoshi Mizoguchi, Naoki Watanabe, and Norimitsu Kadowaki.
2025. "Antitumor Effects of Combination Therapy with Oncolytic Vaccinia Virus and Tepotinib on Lung Cancer Cells" Cancers 17, no. 16: 2681.
https://doi.org/10.3390/cancers17162681
APA Style
Inoue, T., Kanaji, N., Nakamura, T., Yokohira, M., Komori, Y., Ohara, Y., Mizoguchi, H., Watanabe, N., & Kadowaki, N.
(2025). Antitumor Effects of Combination Therapy with Oncolytic Vaccinia Virus and Tepotinib on Lung Cancer Cells. Cancers, 17(16), 2681.
https://doi.org/10.3390/cancers17162681
